SCHEMBL3765818

SCHEMBL3765818

CC#Cc1ncc[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3167431 0.85 ALDH1A1 (0.43)
SCHEMBL13930065 0.83 ALDH1A1 (0.37)
SCHEMBL7300417 0.80
SCHEMBL3168192 0.80 ALDH1A1 (0.40)
SCHEMBL3171707 0.78 ALDH1A1 (0.39)
SCHEMBL3168577 0.78 ALDH1A1 (0.39)
SCHEMBL31375385 0.74 ALDH1A1 (0.43)
SCHEMBL261604 0.73
SCHEMBL27658094 0.71
SCHEMBL678538 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115704810-B Method for measuring content of 2-propyne-1-yl 1H-imidazole-1-carboxylate by high performance liquid chromatography 张家港市国泰华荣化工新材料有限公司 2024-01-02 CN claimed
CN-114094186-A Non-aqueous electrolyte and battery comprising same 珠海冠宇电池股份有限公司 2022-02-25 CN claimed
CN-115704810-A Method for determining content of 2-propyn-1-yl 1H-imidazole-1-carboxylate by high performance liquid chromatography 张家港市国泰华荣化工新材料有限公司 2023-02-17 CN disclosed
WO-2022193179-A1 ELECTROLYTE AND ELECTROCHEMICAL DEVICE COMPRISING SAME 宁德新能源科技有限公司 2022-09-22 WO disclosed
CN-114094186-A Non-aqueous electrolyte and battery comprising same 珠海冠宇电池股份有限公司 2022-02-25 CN disclosed
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed
WO-2009122148-A1 FUSED THIOPHENE AND THIAZOLE DERIVATIVES AS PI3K KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-10-08 WO disclosed
WO-2009071895-A1 FUSED THIAZOLE AND THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-06-11 WO disclosed
WO-2009071890-A1 TRICYCLIC KINASE INHIBITORS UCB PHARMA S.A. (BE) 2009-06-11 WO disclosed
EP-2029570-A1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB Pharma S.A. (BE) 2009-03-04 EP disclosed
WO-2007141504-A1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2007-12-13 WO disclosed
EP-0214600-B1 CEPHALOSPORIN DERIVATIVES Otsuka Kagaku Kabushiki Kaisha (JP) 1992-12-02 EP disclosed
US-4906623-A 3-Imidazolium cephalosporin derivatives OTSUKA KAGAKU KABUSHIKI KAISHA (JP) 1990-03-06 US disclosed
EP-0214600-A2 Cephalosporin derivatives Otsuka Kagaku Kabushiki Kaisha (JP) 1987-03-18 EP disclosed